D.A. Davidson & Co’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.29M | Sell |
5,139
-112
| -2% | -$52.2K | 0.01% | 657 |
|
|
2025
Q4 | $2.38M | Buy |
5,251
+154
| +3% | +$66.4K | 0.01% | 612 |
|
|
2025
Q3 | $2M | Buy |
5,097
+241
| +5% | +$101K | 0.01% | 645 |
|
|
2025
Q2 | $2.16M | Buy |
4,856
+51
| +1% | +$23.5K | 0.02% | 588 |
|
|
2025
Q1 | $2.33M | Sell |
4,805
-349
| -7% | -$163K | 0.02% | 525 |
|
|
2024
Q4 | $2.08M | Sell |
5,154
-321
| -6% | -$149K | 0.02% | 553 |
|
|
2024
Q3 | $2.55M | Buy |
5,475
+611
| +13% | +$294K | 0.02% | 496 |
|
|
2024
Q2 | $2.28M | Sell |
4,864
-22
| -0.5% | -$9.55K | 0.02% | 501 |
|
|
2024
Q1 | $2.04M | Buy |
4,886
+2,427
| +99% | +$1.03M | 0.02% | 529 |
|
|
2023
Q4 | $1M | Sell |
2,459
-904
| -27% | -$334K | 0.01% | 716 |
|
|
2023
Q3 | $1.17M | Buy |
3,363
+110
| +3% | +$38.5K | 0.01% | 630 |
|
|
2023
Q2 | $1.14M | Sell |
3,253
-521
| -14% | -$176K | 0.01% | 649 |
|
|
2023
Q1 | $1.19M | Sell |
3,774
-567
| -13% | -$170K | 0.01% | 617 |
|
|
2022
Q4 | $1.25M | Buy |
4,341
+2,240
| +107% | +$683K | 0.01% | 564 |
|
|
2022
Q3 | $608K | Sell |
2,101
-141
| -6% | -$40.6K | 0.01% | 751 |
|
|
2022
Q2 | $632K | Buy |
2,242
+61
| +3% | +$16.3K | 0.01% | 746 |
|
|
2022
Q1 | $569K | Buy |
2,181
+948
| +77% | +$225K | 0.01% | 841 |
|
|
2021
Q4 | $271K | Sell |
1,233
-3
| -0.2% | -$583 | ﹤0.01% | 1083 |
|
|
2021
Q3 | $224K | Buy |
+1,236
| New | +$241K | ﹤0.01% | 1117 |
|
|
2021
Q2 | – | Sell |
-932
| Closed | -$200K | – | 1218 |
|
|
2021
Q1 | $200K | Buy |
+932
| New | +$205K | ﹤0.01% | 1095 |
|
|
2020
Q4 | – | Sell |
-841
| Closed | -$229K | – | 1041 |
|
|
2020
Q3 | $229K | Buy |
841
+70
| +9% | +$19.3K | ﹤0.01% | 834 |
|
|
2020
Q2 | $224K | Buy |
+771
| New | +$209K | ﹤0.01% | 829 |
|
|
2019
Q2 | – | Sell |
-21,676
| Closed | -$3.99M | – | 1150 |
|
|
2019
Q1 | $3.99M | Sell |
21,676
-624
| -3% | -$115K | 0.07% | 222 |
|
|
2018
Q4 | $3.69M | Sell |
22,300
-233
| -1% | -$40.4K | 0.07% | 217 |
|
|
2018
Q3 | $4.34M | Sell |
22,533
-206
| -0.9% | -$36.7K | 0.08% | 213 |
|
|
2018
Q2 | $3.87M | Sell |
22,739
-672
| -3% | -$104K | 0.08% | 221 |
|
|
2018
Q1 | $3.82M | Sell |
23,411
-301
| -1% | -$49.2K | 0.08% | 210 |
|
|
2017
Q4 | $3.55M | Sell |
23,712
-1,326
| -5% | -$196K | 0.07% | 217 |
|
|
2017
Q3 | $3.81M | Buy |
25,038
+133
| +0.5% | +$20K | 0.07% | 233 |
|
|
2017
Q2 | $3.21M | Buy |
24,905
+447
| +2% | +$53.8K | 0.07% | 219 |
|
|
2017
Q1 | $2.67M | Sell |
24,458
-640
| -3% | -$56.3K | 0.06% | 239 |
|
|
2016
Q4 | $1.85M | Buy |
25,098
+9,058
| +56% | +$737K | 0.04% | 347 |
|
|
2016
Q3 | $1.4M | Buy |
16,040
+25
| +0.2% | +$2.36K | 0.03% | 386 |
|
|
2016
Q2 | $1.38M | Buy |
16,015
+337
| +2% | +$29.1K | 0.04% | 343 |
|
|
2016
Q1 | $1.25M | Buy |
15,678
+738
| +5% | +$66.8K | 0.04% | 363 |
|
|
2015
Q4 | $1.88M | Sell |
14,940
-61
| -0.4% | -$7.36K | 0.06% | 286 |
|
|
2015
Q3 | $1.56M | Buy |
15,001
+134
| +0.9% | +$17.2K | 0.05% | 308 |
|
|
2015
Q2 | $1.83M | Buy |
14,867
+752
| +5% | +$94.8K | 0.06% | 289 |
|
|
2015
Q1 | $1.66M | Sell |
14,115
-1,254
| -8% | -$150K | 0.05% | 303 |
|
|
2014
Q4 | $1.82M | Sell |
15,369
-4,572
| -23% | -$515K | 0.06% | 291 |
|
|
2014
Q3 | $2.24M | Sell |
19,941
-120
| -0.6% | -$11.4K | 0.08% | 252 |
|
|
2014
Q2 | $1.9M | Buy |
20,061
+863
| +4% | +$60.5K | 0.06% | 286 |
|
|
2014
Q1 | $1.36M | Buy |
19,198
+2,677
| +16% | +$212K | 0.05% | 331 |
|
|
2013
Q4 | $1.23M | Buy |
16,521
+5,284
| +47% | +$368K | 0.05% | 344 |
|
|
2013
Q3 | $851K | Buy |
11,237
+852
| +8% | +$67.8K | 0.04% | 386 |
|
|
2013
Q2 | $829K | Buy |
+10,385
| New | +$765K | 0.04% | 367 |
|
Other funds holding VRTX
VCM
VPM
D.A. Davidson & Co's VRTX Position: Q1 2026 in Review
D.A. Davidson & Co reduced its Vertex Pharmaceuticals (VRTX) stake by 2.1% in Q1 2026, selling an estimated $52.2K and leaving 5,139 shares worth $2.29M. The position accounts for 0.01% of the portfolio, ranked #657.
D.A. Davidson & Co first reported a position in VRTX in Q2 2013 and has held it in 46 quarters since. The position peaked at $4.34M in Q3 2018. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- D.A. Davidson & Co held 5,139 shares of Vertex Pharmaceuticals worth $2.29M as of Q1 2026.
- D.A. Davidson & Co sold 112 Vertex Pharmaceuticals shares in Q1 2026, an estimated $52.2K.
- Vertex Pharmaceuticals made up 0.01% of D.A. Davidson & Co's portfolio in Q1 2026, its #657 holding.
- D.A. Davidson & Co first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 46 quarters since.
- D.A. Davidson & Co's Vertex Pharmaceuticals position peaked at $4.34M in Q3 2018.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on D.A. Davidson & Co's 13F filing for Q1 2026, filed 5 May 2026.